RUTGERS, THE STATE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Study of High Dose Vitamin C On Outcome in Cardiac Surgery Patients

Phase 4

Completed

Conditions: Reperfusion Injury

Interventions: Other: 5 % Dextrose Water or Normal Saline
Drug: Ascorbic Acid

First Posted Date: 2010-07-22

Last Posted Date: 2020-10-19

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 57

Registration Number: NCT01167569

Locations: 🇺🇸
Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States

Myocardial Ischemia and Transfusion Pilot

Phase 3

Completed

Conditions: Coronary Artery Disease
Myocardial Infarction
Unstable Angina

Interventions: Biological: Red blood cell transfusion

First Posted Date: 2010-07-22

Last Posted Date: 2019-03-20

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 110

Registration Number: NCT01167582

Locations: 🇺🇸
Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
University of Pittsburgh Data Coordinating Center, Pittsburgh, Pennsylvania, United States

and more 4 locations

Pediatric Temperature Variation in the MRI Scanner Under General Anesthesia

Completed

Conditions: Children Requiring MRI

Interventions: Other: axillary temperature before MRI and after the MRI

First Posted Date: 2010-05-07

Last Posted Date: 2018-06-27

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 120

Registration Number: NCT01119248

Locations: 🇺🇸
University Hospital, Newark, New Jersey, United States

The Effects of Hydrocortisone in Endotoxemia in Normal Volunteers

Phase 1

Completed

Conditions: Infections

Interventions: Biological: Endotoxin, Lipopolysaccharide, LPS
Biological: Endotoxin, Lipopolysaccharide, LPS /Epinephrine
Biological: Placebo
Biological: Hydrocortisone

First Posted Date: 2010-02-09

Last Posted Date: 2014-05-22

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 12

Registration Number: NCT01064986

Locations: 🇺🇸
Rutgers-RWJMS, New Brunswick, New Jersey, United States

Internet-Based Weight-Loss Program for Colorectal Cancer Survivors

Not Applicable

Withdrawn

Conditions: Cancer Survivor
Colorectal Cancer
Weight Changes

Interventions: Behavioral: Internet weight loss intervention

First Posted Date: 2009-12-15

Last Posted Date: 2017-03-06

Lead Sponsor: Rutgers, The State University of New Jersey

Registration Number: NCT01032590

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Isoflurane Preconditioning for Liver Resections

Not Applicable

Terminated

Conditions: Liver Disease

Interventions: Drug: propofol
Drug: isoflurane

First Posted Date: 2009-12-14

Last Posted Date: 2017-03-20

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 8

Registration Number: NCT01031550

Locations: 🇺🇸
UMDNJ-University Hospital, Newark, New Jersey, United States

Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Phase 1

Terminated

Conditions: Metastatic Cancer
Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: riluzole
Radiation: whole-brain radiation therapy

First Posted Date: 2009-11-25

Last Posted Date: 2014-05-02

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 9

Registration Number: NCT01018836

Locations: 🇺🇸
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Trial of Nicotine Nasal Spray as an Aid for Smoking Cessation in Schizophrenia

Phase 4

Completed

Conditions: Smoking Cessation
Schizophrenia

Interventions: Drug: Nicotine Nasal Spray
Behavioral: Behavioral counseling

First Posted Date: 2009-11-10

Last Posted Date: 2014-09-08

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 66

Registration Number: NCT01010477

Locations: 🇺🇸
Rutgers-Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Phase II Study of TPA Plus Dexamethasone & CMT in Hematologic Malignancies

Phase 2

Terminated

Conditions: Leukemia

Interventions: Drug: 12-O-tetradecanoylphorbol-13-acetate
Drug: Dexamethasone
Drug: Choline magnesium trisalicylate

First Posted Date: 2009-11-09

Last Posted Date: 2015-11-04

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 1

Registration Number: NCT01009931

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Phase 2

Completed

Conditions: Colorectal Cancer

Interventions: Drug: hydroxychloroquine

First Posted Date: 2009-11-01

Last Posted Date: 2021-09-21

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 38

Registration Number: NCT01006369

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
🇺🇸
Cooper Hospital/University Medical Center, Camden, New Jersey, United States
🇺🇸
Cancer Institute of New Jersey at Hamilton, Hamilton, New Jersey, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy